✦ LIBER ✦

Pharmacokinetic/Pharmacodynamic Modeling of Crizotinib for Anaplastic Lymphoma Kinase Inhibition and Antitumor Efficacy in Human Tumor Xenograft Mouse Models

✍ Scribed by Yamazaki, S.; Vicini, P.; Shen, Z.; Zou, H. Y.; Lee, J.; Li, Q.; Christensen, J. G.; Smith, B. J.; Shetty, B.

Book ID: 111912617
Publisher: American Society for Pharmacology and Experimental Therapeutics
Year: 2011
Tongue: English
Weight: 507 KB
Volume: 340
Category: Article
ISSN: 0022-3565
DOI: 10.1124/jpet.111.188870

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Semi-Mechanistic Pharmacokinetic/Pharmac

Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts

✍ Tate, S. C.; Cai, S.; Ajamie, R. T.; Burke, T.; Beckmann, R. P.; Chan, E. M.; De 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 509 KB

69 POSTER Evaluating the duel kinase inh

69 POSTER Evaluating the duel kinase inhibitor lapatinib: Bioanalytical method development and pharmacokinetic analysis in mouse, rat, and human and determination of in vivo efficacy in a panel of EGFR wildtype and mutant human tumor xenograft models

✍ J. Cooper; F.E. Nieves; J. Kuhn; C.H. Takimoto; A.W. Tolcher; M.J. Wick 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB